MENU

Event Series


Drug Discovery & Development Virtual Event Series 2025
February 19, 2025 6:00 am Pacific Time

Drug Discovery & Development Virtual Event Series 2025

Drug Discovery & Development Virtual Event Series 2024
February 21, 2024 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2024

Drug Discovery & Development Virtual Event Series 2023
February 22, 2023 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2023

Drug Discovery & Development Virtual Event Series 2022
February 23, 2022 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2022

Drug Discovery & Development Virtual Event Series 2021
February 24, 2021 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2021

Drug Discovery & Development Virtual Event Series 2020
February 26, 2020 6:00 am Pacific Time

Drug Discovery & Development Virtual Event Series 2020

Drug Discovery Virtual Event Series 2018
February 21, 2018 6:00 am Pacific Time

Drug Discovery Virtual Event Series 2018

FEB 27, 2019

Drug Discovery Virtual Event Series 2019

Labroots and the Drug Discovery planning committee are pleased to announce its 2nd annual event in the Drug Discovery Virtual Event Series. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.

Topic's for this years event included: 
  • Novel Strategies for Drug Discovery
    • Next-Generation In Silico Technologies
    • Second Harmonic Generation
    • Synthetic Antibodies/Molecularly Imprinted Polymers
    • Co-Culture Systems
  • Effective Tools for Drug Development
    • Artificial Intelligence
    • Well-designed In Vivo Studies
    • Aptamers
    • Combination Therapies to Overcome Resistance
    • Organ On A Chip
    • Pluripotent Stem Cells
  • Innovative Approaches in Clinical Trials
    • Basket Trials
    • Biomarkers

Drug Discovery 2019 brought together industry leaders from around the world will join together and discuss the advancements, challenges and successes of discovery and development of new medications and therapies. Don't miss the opportunity to participate in this groundbreaking conference, which is absolutely free to all participants.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.


Use #LRdrug to follow the conversation!


Speakers
  • Frank McCormick, PhD

    Professor of the UCSF Helen Diller Family Comprehensive Cancer Center
    BIOGRAPHY
  • Mark Hellewell, PhD

    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
    BIOGRAPHY
  • Christopher Bunker, PhD

    Vice President of Business Development, Advanced Cell Diagnostics
    BIOGRAPHY
  • G. Thomas Caltagirone, PhD

    President & CEO, Aptagen, LLC
    BIOGRAPHY
  • Jay Campbell

    Chief Commercial Officer, Somark Innovations
    BIOGRAPHY
  • Maude Champagne

    Clinical Oncology Marketing, Illumina, Inc.
    BIOGRAPHY
  • Richard Eglen, PhD

    Vice President and General Manager, Corning Life Sciences
    BIOGRAPHY
  • Phillip Febbo, MD

    Chief Medical Officer, Illumina, Inc.
    BIOGRAPHY
  • Matthew Flegal, BS, SRS

    Associate Director, Charles River Laboratories
    BIOGRAPHY
  • Bill Jackson, PhD

    Founder and Chief Scientist, Base Pair Biotechnologies
    BIOGRAPHY
  • Adrian Kinkaid

    CEO, MIP Diagnostics
    BIOGRAPHY
  • Jagath Reddy Junutula, PhD

    Senior Vice President, Research & Development, ModMab Therapeutics, Inc.
    BIOGRAPHY
  • Shivaani Kummar, MD, FACP

    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford), Director Phase I Clinical Research, Director, Translational Oncology Program, Stanford University
    BIOGRAPHY
  • Marcel Perret-Gentil, DVM, MS

    University Veterinarian & Director, Laboratory Animal Resources Center, University of Texas at San Antonio
    BIOGRAPHY
  • Devendra Mistry, PhD

    Senior Field Application Scientist, QIAGEN Advanced Genomics
    BIOGRAPHY
  • Elena Naumovska, PhD

    Scientist of Application Development, Mimetas - The Organ on a Chip Company
    BIOGRAPHY
  • Lotta Raty

    Global Product Manager Cell Separation, Miltenyi Biotec
    BIOGRAPHY
  • Khyati Shah, PhD

    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • Martin Shaw

    Business Development, AroCell AB
    BIOGRAPHY
  • Matthew K. Shipton, MS

    Chief Operating Officer, HµREL Corporation
    BIOGRAPHY
  • Sarah Warren, PhD

    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
  • Alex Zhavoronkov, PhD

    Founder and CEO, Insilico Medicine, Inc.
    BIOGRAPHY

You May Also Like

Agenda

  • FEB 27, 2019 3:00 PM PST

    Automation Meets Cell Separation: Primary Cells for Drug Discovery Assays

    Lotta Raty
    Global Product Manager Cell Separation, Miltenyi Biotec
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • FEB 27, 2019 3:00 PM PST

    BASKET Trials: Biomarker Driven Drug Development

    Shivaani Kummar, MD, FACP
    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford), Director Phase I Clinical Research, Director, Translational Oncology Program, Stanford University
    BIOGRAPHY
  • FEB 27, 2019 3:00 PM PST

    Do You Have the Gut-on-a-Chip?

    Elena Naumovska, PhD
    Scientist of Application Development, Mimetas - The Organ on a Chip Company
    BIOGRAPHY
  • FEB 27, 2019 3:00 PM PST

    Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates

    Jagath Reddy Junutula, PhD
    Senior Vice President, Research & Development, ModMab Therapeutics, Inc.
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Advanced Liver Tissue Model for Improved in Vitro Prediction

    Matthew K. Shipton, MS
    Chief Operating Officer, HµREL Corporation
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Advances in Three-Dimensional Cell Culture in Drug Research and Discovery

    Richard Eglen, PhD
    Vice President and General Manager, Corning Life Sciences
    BIOGRAPHY
  • Application of Pharmacogenomics During Clinical Trials
    FEB 27, 2019 1:30 PM PST

    Application of Pharmacogenomics During Clinical Trials

    Annette Gilchrist, PhD
    Associate-Professor, Pharmaceutical Sciences, Midwestern University
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Aptamers in Drug Development: From Biomarker Discovery to Targeted Drug Delivery to Small Molecule Drug Detection

    Bill Jackson, PhD
    Founder and Chief Scientist, Base Pair Biotechnologies
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events Using TruSightTM Oncology 500

    Sponsored By: Illumina
    Phillip Febbo, MD
    Chief Medical Officer, Illumina, Inc.
    Maude Champagne
    Clinical Oncology Marketing, Illumina, Inc.
  • FEB 27, 2019 12:00 PM PST

    Evaluating Biomarkers for Response to Neoadjuvant Immune Checkpoint Blockade in Melanoma

    Sarah Warren, PhD
    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • FEB 27, 2019 12:00 PM PST

    Nanostructured Molecularly Imprinted Polymers: Robust, Stable and Selective Alternatives to Antibodies

    Adrian Kinkaid
    CEO, MIP Diagnostics
    BIOGRAPHY
  • FEB 27, 2019 12:00 PM PST

    Studies on Malignancies With a Novel Proliferation Biomarker

    Martin Shaw
    Business Development, AroCell AB
    BIOGRAPHY
  • FEB 27, 2019 12:00 PM PST

    Why Pain Control Is Good Science-The Scientific Rationale

    Marcel Perret-Gentil, DVM, MS
    University Veterinarian & Director, Laboratory Animal Resources Center, University of Texas at San Antonio
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    Developing Precision Combination Therapies to Overcome Evolution of Therapeutic Resistance

    Khyati Shah, PhD
    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    In Vivo Surgical Models for Drug Discovery: Hidden Pitfalls and Their Avoidance

    Matthew Flegal, BS, SRS
    Associate Director, Charles River Laboratories
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    Synthetic Antibodies - The Emerging Field of "Aptamers" in Diagnostics and Drug Discovery

    G. Thomas Caltagirone, PhD
    President & CEO, Aptagen, LLC
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    The Current State-of-the-Art Tissue Expression Analysis Platform for Detection & Quantification of Target & Biomarker mRNAs, Splice Variants and Mutations in Preclinical & Clinical Tissues

    Christopher Bunker, PhD
    Vice President of Business Development, Advanced Cell Diagnostics
    BIOGRAPHY
    Sponsored By: Advanced Cell Diagnostics
  • FEB 27, 2019 9:00 AM PST

    Keynote Presentation: Fully Automated IHC Multiplexing: Techniques and Assay Development

    Mark Hellewell, PhD
    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
    BIOGRAPHY
    Sponsored By: Roche Diagnostics
  • FEB 27, 2019 7:30 AM PST

    Keynote Presentation: Second Harmonic Generation Detection of Ras Conformational Changes and Discovery of a Novel Small-Molecule Binder

    Frank McCormick, PhD
    Professor of the UCSF Helen Diller Family Comprehensive Cancer Center
    BIOGRAPHY
  • FEB 27, 2019 6:00 AM PST

    Biomarkers of Aging

    Alex Zhavoronkov, PhD
    Founder and CEO, Insilico Medicine, Inc.
    BIOGRAPHY
  • FEB 27, 2019 6:00 AM PST

    Discovering Cellular Mechanisms and Biomarkers in Anti-PD1 Non-Responders Using Ingenuity Pathway Analysis Software and OmicSoft OncoLand Datasets from QIAGEN

    Devendra Mistry, PhD
    Senior Field Application Scientist, QIAGEN Advanced Genomics
    BIOGRAPHY
    Sponsored By: QIAGEN
  • Keynote Presentation: Reimagining Drug Discovery and Development Journey Through AI
    FEB 27, 2019 6:00 AM PST

    Keynote Presentation: Reimagining Drug Discovery and Development Journey Through AI

    Szczepan Baran, VMD, MS
    Head of Emerging Technologies, LAS, Novartis
    BIOGRAPHY
  • FEB 27, 2019 6:00 AM PST

    The Missing Link to Improving Efficiency and Productivity in the Digital Lab

    Jay Campbell
    Chief Commercial Officer, Somark Innovations
    BIOGRAPHY
  • Effective Tools for Drug Development
  • FEB 27, 2019 6:00 AM PST

    Biomarkers of Aging

    Alex Zhavoronkov, PhD
    Founder and CEO, Insilico Medicine, Inc.
    BIOGRAPHY
  • Keynote Presentation: Reimagining Drug Discovery and Development Journey Through AI
    FEB 27, 2019 6:00 AM PST

    Keynote Presentation: Reimagining Drug Discovery and Development Journey Through AI

    Szczepan Baran, VMD, MS
    Head of Emerging Technologies, LAS, Novartis
    BIOGRAPHY
  • FEB 27, 2019 6:00 AM PST

    Discovering Cellular Mechanisms and Biomarkers in Anti-PD1 Non-Responders Using Ingenuity Pathway Analysis Software and OmicSoft OncoLand Datasets from QIAGEN

    Devendra Mistry, PhD
    Senior Field Application Scientist, QIAGEN Advanced Genomics
    BIOGRAPHY
    Sponsored By: QIAGEN
  • FEB 27, 2019 6:00 AM PST

    The Missing Link to Improving Efficiency and Productivity in the Digital Lab

    Jay Campbell
    Chief Commercial Officer, Somark Innovations
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    The Current State-of-the-Art Tissue Expression Analysis Platform for Detection & Quantification of Target & Biomarker mRNAs, Splice Variants and Mutations in Preclinical & Clinical Tissues

    Christopher Bunker, PhD
    Vice President of Business Development, Advanced Cell Diagnostics
    BIOGRAPHY
    Sponsored By: Advanced Cell Diagnostics
  • FEB 27, 2019 12:00 PM PST

    Evaluating Biomarkers for Response to Neoadjuvant Immune Checkpoint Blockade in Melanoma

    Sarah Warren, PhD
    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • FEB 27, 2019 1:30 PM PST

    Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events Using TruSightTM Oncology 500

    Sponsored By: Illumina
    Phillip Febbo, MD
    Chief Medical Officer, Illumina, Inc.
    Maude Champagne
    Clinical Oncology Marketing, Illumina, Inc.
  • FEB 27, 2019 1:30 PM PST

    Advanced Liver Tissue Model for Improved in Vitro Prediction

    Matthew K. Shipton, MS
    Chief Operating Officer, HµREL Corporation
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Advances in Three-Dimensional Cell Culture in Drug Research and Discovery

    Richard Eglen, PhD
    Vice President and General Manager, Corning Life Sciences
    BIOGRAPHY
  • FEB 27, 2019 3:00 PM PST

    Automation Meets Cell Separation: Primary Cells for Drug Discovery Assays

    Lotta Raty
    Global Product Manager Cell Separation, Miltenyi Biotec
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • FEB 27, 2019 3:00 PM PST

    Do You Have the Gut-on-a-Chip?

    Elena Naumovska, PhD
    Scientist of Application Development, Mimetas - The Organ on a Chip Company
    BIOGRAPHY
  • Novel Strategies for Drug Discovery
  • FEB 27, 2019 7:30 AM PST

    Keynote Presentation: Second Harmonic Generation Detection of Ras Conformational Changes and Discovery of a Novel Small-Molecule Binder

    Frank McCormick, PhD
    Professor of the UCSF Helen Diller Family Comprehensive Cancer Center
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    In Vivo Surgical Models for Drug Discovery: Hidden Pitfalls and Their Avoidance

    Matthew Flegal, BS, SRS
    Associate Director, Charles River Laboratories
    BIOGRAPHY
  • FEB 27, 2019 10:30 AM PST

    Synthetic Antibodies - The Emerging Field of "Aptamers" in Diagnostics and Drug Discovery

    G. Thomas Caltagirone, PhD
    President & CEO, Aptagen, LLC
    BIOGRAPHY
  • FEB 27, 2019 12:00 PM PST

    Why Pain Control Is Good Science-The Scientific Rationale

    Marcel Perret-Gentil, DVM, MS
    University Veterinarian & Director, Laboratory Animal Resources Center, University of Texas at San Antonio
    BIOGRAPHY
  • FEB 27, 2019 12:00 PM PST

    Nanostructured Molecularly Imprinted Polymers: Robust, Stable and Selective Alternatives to Antibodies

    Adrian Kinkaid
    CEO, MIP Diagnostics
    BIOGRAPHY
  • FEB 27, 2019 1:30 PM PST

    Aptamers in Drug Development: From Biomarker Discovery to Targeted Drug Delivery to Small Molecule Drug Detection

    Bill Jackson, PhD
    Founder and Chief Scientist, Base Pair Biotechnologies
    BIOGRAPHY
  • FEB 27, 2019 3:00 PM PST

    Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates

    Jagath Reddy Junutula, PhD
    Senior Vice President, Research & Development, ModMab Therapeutics, Inc.
    BIOGRAPHY
  • Innovative Approaches in Clinical Trials
  • FEB 27, 2019 9:00 AM PST

    Keynote Presentation: Fully Automated IHC Multiplexing: Techniques and Assay Development

    Mark Hellewell, PhD
    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
    BIOGRAPHY
    Sponsored By: Roche Diagnostics
  • FEB 27, 2019 10:30 AM PST

    Developing Precision Combination Therapies to Overcome Evolution of Therapeutic Resistance

    Khyati Shah, PhD
    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • FEB 27, 2019 12:00 PM PST

    Studies on Malignancies With a Novel Proliferation Biomarker

    Martin Shaw
    Business Development, AroCell AB
    BIOGRAPHY
  • Application of Pharmacogenomics During Clinical Trials
    FEB 27, 2019 1:30 PM PST

    Application of Pharmacogenomics During Clinical Trials

    Annette Gilchrist, PhD
    Associate-Professor, Pharmaceutical Sciences, Midwestern University
    BIOGRAPHY
  • FEB 27, 2019 3:00 PM PST

    BASKET Trials: Biomarker Driven Drug Development

    Shivaani Kummar, MD, FACP
    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford), Director Phase I Clinical Research, Director, Translational Oncology Program, Stanford University
    BIOGRAPHY

Speakers


  • Frank McCormick, PhD

    Frank McCormick, PhD

    Professor of the UCSF Helen Diller Family Comprehensive Cancer Center

    BIOGRAPHY
  • Mark Hellewell, PhD

    Mark Hellewell, PhD

    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics

    BIOGRAPHY
  • Christopher Bunker, PhD

    Christopher Bunker, PhD

    Vice President of Business Development, Advanced Cell Diagnostics

    BIOGRAPHY
  • G. Thomas Caltagirone, PhD

    G. Thomas Caltagirone, PhD

    President & CEO, Aptagen, LLC

    BIOGRAPHY
  • Jay Campbell

    Jay Campbell

    Chief Commercial Officer, Somark Innovations

    BIOGRAPHY
  • Maude Champagne

    Maude Champagne

    Clinical Oncology Marketing, Illumina, Inc.

    BIOGRAPHY
  • Richard Eglen, PhD

    Richard Eglen, PhD

    Vice President and General Manager, Corning Life Sciences

    BIOGRAPHY
  • Phillip Febbo, MD

    Phillip Febbo, MD

    Chief Medical Officer, Illumina, Inc.

    BIOGRAPHY
  • Matthew Flegal, BS, SRS

    Matthew Flegal, BS, SRS

    Associate Director, Charles River Laboratories

    BIOGRAPHY
  • Bill Jackson, PhD

    Bill Jackson, PhD

    Founder and Chief Scientist, Base Pair Biotechnologies

    BIOGRAPHY
  • Adrian Kinkaid

    Adrian Kinkaid

    CEO, MIP Diagnostics

    BIOGRAPHY
  • Jagath Reddy Junutula, PhD

    Jagath Reddy Junutula, PhD

    Senior Vice President, Research & Development, ModMab Therapeutics, Inc.

    BIOGRAPHY
  • Shivaani Kummar, MD, FACP

    Shivaani Kummar, MD, FACP

    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford), Director Phase I Clinical Research, Director, Translational Oncology Program, Stanford University

    BIOGRAPHY
  • Marcel Perret-Gentil, DVM, MS

    Marcel Perret-Gentil, DVM, MS

    University Veterinarian & Director, Laboratory Animal Resources Center, University of Texas at San Antonio

    BIOGRAPHY
  • Devendra Mistry, PhD

    Devendra Mistry, PhD

    Senior Field Application Scientist, QIAGEN Advanced Genomics

    BIOGRAPHY
  • Elena Naumovska, PhD

    Elena Naumovska, PhD

    Scientist of Application Development, Mimetas - The Organ on a Chip Company

    BIOGRAPHY
  • Lotta Raty

    Lotta Raty

    Global Product Manager Cell Separation, Miltenyi Biotec

    BIOGRAPHY
  • Khyati Shah, PhD

    Khyati Shah, PhD

    Post Doctoral Research Scholar at University of California, San Francisco

    BIOGRAPHY
  • Martin Shaw

    Martin Shaw

    Business Development, AroCell AB

    BIOGRAPHY
  • Matthew K. Shipton, MS

    Matthew K. Shipton, MS

    Chief Operating Officer, HµREL Corporation

    BIOGRAPHY
  • Sarah Warren, PhD

    Sarah Warren, PhD

    Senior Director of Advanced Applications, NanoString Technologies

    BIOGRAPHY
  • Alex Zhavoronkov, PhD

    Alex Zhavoronkov, PhD

    Founder and CEO, Insilico Medicine, Inc.

    BIOGRAPHY
Posters

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Program Committee

To download the Program Committee brochure here.


  • Annette Gilchrist

    An Associate Professor with Midwestern University, Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she was with Cue Biotech and Caden Biosciences, companies she ...

    See more See less
  • Matthew Flegal

    Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

    See more See less
  • Khyati Shah

    Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

    See more See less
  • Martin Shaw

    Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...

    See more See less
  • Matthew Shipton

    Over the past 16 years, Mr. Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as President of Novabiosis, Inc. Mr. Shipton brings a skill for implementing sales-driven business strategies, an extensive track record of meeting and ...

    See more See less
  • Sid Topiol

    Sid Topiol is the founder and CSO of 3D-2drug LLC, a collaborative research organization incubating drug discovery projects. 3D-2drug is rooted in the deployment of protein structure/function information into novel and efficient drug discovery opportunities. Sid received his B.S ...

    See more See less
Help

Demographics

Loading Comments...